300K settlement follows unlawful prescribing claims - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

300K settlement follows unlawful prescribing claims

The federal settlement resolves allegations of unlawful controlled substance prescribing and absent patient records and restricts future DEA registration for certain controlled substances.

  • By

  • Kathryn Wighton

  • October 1, 2026

  • 2 min

Share

  • 1

    Dr. Twan Phanijphand reached a $300,000 civil settlement with federal authorities over unlawful prescribing allegations.

  • 2

    Phanijphand allegedly prescribed at least 127 controlled substance prescriptions without maintaining patient records.

  • 3

    The prescriptions included opioids and other controlled substances such as oxycodone-acetaminophen and alprazolam.

  • 4

    He voluntarily surrendered his DEA registration on April 22, 2026, as part of the settlement agreement.

  • 5

    The settlement requires Phanijphand to complete continuing education and undergo additional DEA monitoring.

Original Source(s)

300K settlement follows unlawful prescribing claims

  • by Kathryn Wighton

  • October 1, 2026

Related Content

Postop Pain Differs by Vitamin D Status

Patients with preoperative vitamin D deficiency had higher postoperative pain scores and opioid use after mastectomy, including more than triple the odds of moderate to severe pain within 24 hours of surgery.

Prescribing Outside the Exam Room

A DEA case exposes how controlled substances can move outside clinical oversight.

Online Program Eases Pediatric Trauma Stress

Randomized trial evaluated therapist-assisted intervention among pediatric patients with persistent symptoms 1 month following trauma